{'fraction_non_alphanumeric': 0.026359143327841845, 'fraction_numerical': 0.0, 'mean_word_length': 5.681318681318682, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Efficacy of ibrutinib in the treatment of Bing–Neel syndrome

Writing assistance in the development of this manuscript was provided by Jim Kesslick and Nicholas C. Stilwell of Connexion Healthcare (Newtown, PA); editorial support provided by Tmirah Haselkorn, PhD of EpiMetrix (Los Altos, CA). Alexion Pharmaceuticals provided funding for these services. The authors meet criteria for authorship as recommended by the International Committee of Medical Journal Editors (ICMJE) and were fully responsible for all content and editorial decisions, and were involved at all stages of correspondence development.